For retail sale medicaments with penicillins or streptomycins market in Romania

Earlier Report Observations

Between 2018 and 2021, the Romanian market for retail-packed penicillins operated under the stable regulatory oversight of the National Agency for Medicines and Medical Devices (ANMDM), which enforced strict guidelines on administration and disposal. The market size showed modest fluctuations, declining slightly from 38.2 million USD in 2019 to 36.6 million USD in 2021. Throughout this period, Antibiotice Iași remained the sole domestic producer of sterile injectable penicillins, benefiting from its historical FDA approval for streptomycin since 1977.

From 2022, the market entered a pronounced growth phase, reaching 41.6 million USD in 2022 and surging to 55.5 million USD in 2023. This expansion was primarily driven by Antibiotice Iași's successful international market penetration, including entries into the United Arab Emirates and Australia, alongside increased sales in Saudi Arabia and Iraq. Domestically, the company's turnover grew by 5% due to redefined distributor partnerships, while consumer preference for injectable forms, which saw a 17% volume increase, further boosted production. In 2024, the market adjusted to 53.8 million USD as Antibiotice Iași consolidated its global position by winning a major 5 million euro tender to supply five sterile beta-lactam penicillins to British hospitals.

Production for retail sale medicaments with penicillins or streptomycins in Romania

In value, 2017-2020, K $ US

In 2020, Romania's output of retail sale medicaments containing penicillins or streptomycins was valued at 26 765 thousand US dollars, marking a modest 8.0% decrease compared to the previous year.

Annual dynamics of production in Romania in value, 2017-2020, K $ US

Exports for retail sale medicaments with penicillins or streptomycins from Romania

Exports in kind, t

Romania's exports of retail sale medicaments with penicillins or streptomycins declined in 2020 after two years of growth. That year, exports amounted to 578.4 tonnes, representing a 13.2% year-over-year drop. Over the period from 2017 to 2020, exports increased by 87.9%, with a compound annual growth rate of 23.4%. The peak was recorded in 2019 at 666.3 tonnes, while the largest annual increase occurred in 2018 at 66.3%.

Annual dynamics of product's exports from Romania in kind, 2017-2020, t

From 2017 to 2020, Vietnam, France, and the Netherlands formed the core of Romania's exports in kind for these medicaments. Vietnam accounted for 37.7% of exports, France for 21.9%, and the Netherlands for 11.9%, together representing 71.5% of total export flows.

Structure of product's exports in kind by countries, 2017-2020

World map of product's exports from Romania in kind, 2017-2020

Exports in value, K $ US

Romania's foreign supplies of retail sale medicaments with penicillins or streptomycins increased for the third consecutive year in 2020. Exports totalled 18 154 thousand US dollars, reflecting a 2.1% advance compared to the previous year. Over the 2017-2020 period, exports grew by 51.2%, with a compound annual growth rate of 14.8%.

Annual dynamics of product's exports from Romania in value, 2017-2020, K $ US

Between 2017 and 2020, the main markets for Romania's exports in value terms were Vietnam, the United States, and France. Vietnam accounted for 39.7% of exports, the United States for 15.8%, and France for 7.3%, together making up 62.8% of total export flows.

Structure of product's exports in value by countries, 2017-2020

World map of product's exports from Romania in value, 2017-2020

Imports for retail sale medicaments with penicillins or streptomycins to Romania

Imports in kind, t

In 2020, Romania's imports of retail sale medicaments with penicillins or streptomycins amounted to 531.6 tonnes, down by 3.7% compared to the previous year. Between 2017 and 2020, imports decreased by 34.8%, equating to an annualized rate of 13.3%. The lowest value was recorded in 2018 at 492.4 tonnes, which also saw the largest annual decline of 39.7%. In contrast, the largest increase occurred in 2019 at 12.2%.

Annual dynamics of product's imports to Romania in kind, 2017-2020, t

Throughout 2017-2020, the United Kingdom, Slovenia, and Austria were the three largest markets for Romania's imports in kind of these medicaments, together accounting for 66.5% of total import flows.

Structure of product's imports in kind by countries, 2017-2020

World map of product's imports to Romania in kind, 2017-2020

Imports in value, K $ US

After a two-year decline, cross-border shipments of retail sale medicaments with penicillins or streptomycins to Romania increased in 2020. Imports amounted to 28 607 thousand US dollars, showing a modest 6.4% year-over-year improvement. The lowest value was recorded in 2019 at 26 877 thousand US dollars, while the largest annual decline occurred in 2018 at 6.2%.

Annual dynamics of product's imports to Romania in value, 2017-2020, K $ US

From 2017 to 2020, the leading destinations for Romania's imports in value terms of these medicaments were the United Kingdom, France, and Slovenia. The United Kingdom accounted for 36.4% of imports, France for 22.9%, and Slovenia for 10.6%, jointly representing 69.9% of total import flows.

Structure of product's imports in value by countries, 2017-2020

World map of product's imports to Romania in value, 2017-2020